25 Feb 2021Ended

A New Platform for Clinical Gene Editing of iPSCs to Make Clonal Cell Banks


Estimated Turnout

upto 100
Based on previous editions


Feb 2021


Not Available
Claim event to edit details

However, somewhat analogous to monoclonal antibodies 20 years ago, the editing and single-cell cloning of stem cells has, up until now, largely .. Read more been a black art reserved for experts. There is also great variation between groups and labs. Stem cells are inherently very sensitive to fluorescence-activated cell sorting (FACS) and culture conditions and their viability is typically poor when cloned. Solentim now presents a platform combination of instrumentation (the VIPS) and soluble matrix (MatriClone, based on laminin) for the high-efficiency, high-viability single-cell cloning of iPSCs to form the Master Cell Bank. This includes an industry-leading clonality documentation package to support future investigational new drugs (INDs). Most current instrumentation for stem cell isolation and cloning is only suitable for use in a research environment. Solentim realizes the need for cell therapy customers to implement systems in research now which can then be replicated and used in their clinical manufacturing.

  • Share your Experience
  • Organizer
Logo Follow Company


Canada355 Total Events / 44 Upcoming Events

More Events From The Organizer